BRPI0517122A - composição, seu uso e método para a melhora da concentração do foco mental e/ou da disposição - Google Patents

composição, seu uso e método para a melhora da concentração do foco mental e/ou da disposição

Info

Publication number
BRPI0517122A
BRPI0517122A BRPI0517122-9A BRPI0517122A BRPI0517122A BR PI0517122 A BRPI0517122 A BR PI0517122A BR PI0517122 A BRPI0517122 A BR PI0517122A BR PI0517122 A BRPI0517122 A BR PI0517122A
Authority
BR
Brazil
Prior art keywords
composition
mood
mental focus
improving mental
concentration
Prior art date
Application number
BRPI0517122-9A
Other languages
English (en)
Inventor
Gail Nicola Owen
Jane Rycroft
Andrew Belton Scholey
David Stephen Scott
Original Assignee
Unilever Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34930897&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0517122(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Unilever Nv filed Critical Unilever Nv
Publication of BRPI0517122A publication Critical patent/BRPI0517122A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23FCOFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
    • A23F3/00Tea; Tea substitutes; Preparations thereof
    • A23F3/16Tea extraction; Tea extracts; Treating tea extract; Making instant tea
    • A23F3/30Further treatment of dried tea extract; Preparations produced thereby, e.g. instant tea
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23FCOFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
    • A23F3/00Tea; Tea substitutes; Preparations thereof
    • A23F3/06Treating tea before extraction; Preparations produced thereby
    • A23F3/14Tea preparations, e.g. using additives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23FCOFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
    • A23F3/00Tea; Tea substitutes; Preparations thereof
    • A23F3/16Tea extraction; Tea extracts; Treating tea extract; Making instant tea
    • A23F3/163Liquid or semi-liquid tea extract preparations, e.g. gels, liquid extracts in solid capsules
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Dispersion Chemistry (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Tea And Coffee (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Confectionery (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

COMPOSIçãO, SEU USO E MéTODO PARA A MELHORA DA CONCENTRAçãO DO FOCO MENTAL EI OU DA DISPOSIçãO. A presente invenção refere-se a uma composição adequada para o consumo direto humano que compreende (A) de 300 a 3.000 ppm de teanina; e (B) de 200 a 2.000 ppm de cafeina e em que é fornecida a proporção de teanina e cafeina sendo de 5:1 a 1:1,5 e é mostrada para fornecer melhoras notáveis na concentração, no foco mental e/ou na disposição quando consumidas.
BRPI0517122-9A 2004-12-08 2005-11-18 composição, seu uso e método para a melhora da concentração do foco mental e/ou da disposição BRPI0517122A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04257634 2004-12-08
PCT/EP2005/012464 WO2006061097A1 (en) 2004-12-08 2005-11-18 Food or beverage product comprising theanine and caffeine for enhancing mental alertness

Publications (1)

Publication Number Publication Date
BRPI0517122A true BRPI0517122A (pt) 2008-09-30

Family

ID=34930897

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0517122-9A BRPI0517122A (pt) 2004-12-08 2005-11-18 composição, seu uso e método para a melhora da concentração do foco mental e/ou da disposição

Country Status (19)

Country Link
US (1) US20060159829A1 (pt)
EP (2) EP2108270B2 (pt)
JP (2) JP4499652B2 (pt)
CN (1) CN101076259B (pt)
AR (1) AR051704A1 (pt)
AT (1) ATE500753T1 (pt)
AU (1) AU2005313636B2 (pt)
BR (1) BRPI0517122A (pt)
CA (1) CA2589696A1 (pt)
DE (1) DE602005026878D1 (pt)
ES (1) ES2359042T3 (pt)
MX (1) MX2007006633A (pt)
MY (1) MY144727A (pt)
PL (2) PL1819241T3 (pt)
PT (2) PT1819241E (pt)
RU (2) RU2392836C2 (pt)
SA (1) SA05260394B1 (pt)
WO (1) WO2006061097A1 (pt)
ZA (1) ZA200704521B (pt)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2006033300A1 (ja) * 2004-09-22 2008-05-15 太陽化学株式会社 密封容器入り飲料
US20060134301A1 (en) * 2004-12-22 2006-06-22 Unilever Bestfoods, North America, Division Of Conopco, Inc. Method for making a food composition with a preservative free enhancer and a food composition
RU2009103623A (ru) * 2006-07-04 2010-08-10 Унилевер Н.В. (NL) Производные теанина, их применение и способы их получения
JP2010527918A (ja) 2007-05-11 2010-08-19 ユニリーバー・ナームローゼ・ベンノートシヤープ テアニンを精製する方法
GB2450076B (en) * 2007-05-17 2012-09-26 Sis Science In Sport Ltd Nutritional composition
US8945655B2 (en) * 2007-07-10 2015-02-03 Conopco, Inc. Stable and consumable compositions
EP2192843B1 (en) * 2007-09-19 2011-06-01 Unilever PLC Beverage precursor and process for the manufacture thereof
RU2487645C2 (ru) * 2007-11-16 2013-07-20 Интернешнл АйПи Холдингс ЭлЭлСи Пищевая энергетическая композиция с низким содержанием кофеина
US20090155420A1 (en) * 2007-12-12 2009-06-18 Conopco, Inc., D/B/A Unilever Food product with stabilized non-protein amino acids
US20100151104A1 (en) * 2008-10-27 2010-06-17 Pepsico, Inc. Preservative System For Beverages Based On Combinations Of Trans-Cinnamic Acid, Lauric Arginate, And Dimethyl Dicarbonate
EA019809B9 (ru) * 2008-11-11 2014-08-29 Юнилевер Нв Композиция черного чая
JP5739614B2 (ja) * 2009-11-09 2015-06-24 サントリー食品インターナショナル株式会社 アミノ酸を高濃度に含有する茶飲料
JP5118163B2 (ja) * 2010-01-29 2013-01-16 株式会社 伊藤園 容器詰緑茶飲料
JP5118164B2 (ja) * 2010-01-29 2013-01-16 株式会社 伊藤園 容器詰緑茶飲料
EP2549880B1 (en) 2010-03-25 2014-09-10 Unilever PLC Process for manufacturing tea products
CN101828614B (zh) * 2010-05-13 2013-01-02 遵义陆圣康源科技开发有限责任公司 速溶型天然茶叶儿茶素、茶氨酸及水苏糖固体饮品
CA2798911C (en) 2010-05-19 2018-07-03 Unilever Plc Theobromine for increasing hdl-cholesterol
JP5789089B2 (ja) * 2010-07-05 2015-10-07 サントリー食品インターナショナル株式会社 集中力向上剤
RU2489892C1 (ru) * 2012-03-21 2013-08-20 Владимир Евгеньевич Мильтюсов Способ производства молочно-фруктового напитка
RU2516117C2 (ru) * 2012-08-20 2014-05-20 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Российский государственный педагогический университет им. А.И. Герцена" Способ оптимизации интеллектуальной деятельности обучающихся
AU2014348672A1 (en) * 2013-11-12 2016-06-02 Ortho-Nutra, Llc Theacrine-based supplement and method of use thereof
US11102994B2 (en) * 2014-08-21 2021-08-31 Clearfast Inc. Pre-operative carbohydrate-rich beverage composition and methods of treatment
US10441535B2 (en) * 2014-12-29 2019-10-15 NeuroGum, LLC Nutraceutical confectionary composition containing caffeine and L-theanine
JP6050862B2 (ja) * 2015-06-10 2016-12-21 サントリー食品インターナショナル株式会社 集中力向上剤
JP6717590B2 (ja) * 2015-11-26 2020-07-01 キリンビバレッジ株式会社 異味が低減された容器詰めクエン酸高含有酸性飲料
JP6396970B2 (ja) * 2016-11-18 2018-09-26 サントリーホールディングス株式会社 集中力向上剤
RU2707943C1 (ru) * 2018-12-05 2019-12-02 Гринми Са Напиток тонизирующий безалкогольный газированный
CN113841760A (zh) * 2021-09-30 2021-12-28 北京小罐茶业有限公司 一种茶与咖啡混合的饮料及其制备方法
GB202214775D0 (en) 2022-10-07 2022-11-23 Nicoventures Trading Ltd Oral product
WO2024074842A1 (en) 2022-10-07 2024-04-11 Nicoventures Trading Limited Oral product
GB202214803D0 (en) 2022-10-07 2022-11-23 Nicoventures Trading Ltd Oral product
GB202214771D0 (en) 2022-10-07 2022-11-23 Nicoventures Trading Ltd Oral product
WO2024074839A1 (en) 2022-10-07 2024-04-11 Nicoventures Trading Limited Oral product
WO2024074843A1 (en) 2022-10-07 2024-04-11 Nicoventures Trading Limited Oral product
GB202216465D0 (en) 2022-11-04 2022-12-21 Nicoventures Trading Ltd Oral product
WO2024095011A1 (en) 2022-11-04 2024-05-10 Nicoventures Trading Limited Oral product
CN117599062A (zh) * 2023-11-23 2024-02-27 安徽农业大学 一种辅助改善记忆、预防或治疗阿尔茨海默病的组合物

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4906655A (en) * 1989-01-24 1990-03-06 Warner-Lambert Company Novel 1,2-cyclohexylaminoaryl amides useful as analgesic agents
US6294520B1 (en) * 1989-03-27 2001-09-25 Albert T. Naito Material for passage through the blood-brain barrier
US5501866A (en) 1990-12-02 1996-03-26 Ito En, Ltd. Product and method for inhibiting caffeine stimulation with theanine
US5852058A (en) * 1993-06-11 1998-12-22 The Board Of Trustees Of The Leland Stanford Junior University Intramural delivery of nitric oxide enhancer for inhibiting lesion formation after vascular injury
JPH09501311A (ja) * 1993-06-23 1997-02-10 ダブリューエム リグリー ジュニア カンパニー 改良されたチューイングガムおよびキャンディー製品
AU1525695A (en) * 1994-01-10 1995-08-01 Procter & Gamble Company, The Tea extract and process for preparing
ATE198255T1 (de) * 1994-08-08 2001-01-15 Procter & Gamble Tee und obstsaft enthaltende zusammensetzungen mit einer stabile farbe
US6063428A (en) 1996-02-26 2000-05-16 The Procter & Gamble Company Green tea extract subjected to cation exchange treatment and nanofiltration to improve clarity and color
JP2002503855A (ja) * 1998-02-17 2002-02-05 サン・マイクロシステムズ・インコーポレーテッド 可変解像度スーパーサンプリングによるグラフィックス・システム
CA2320368C (en) * 1998-02-23 2007-08-21 Taiyo Kagaku Co., Ltd. Composition comprising theanine
US6036985A (en) 1998-04-03 2000-03-14 Nestec S.A. Calcium complex and food fortified therewith
US7655423B2 (en) * 1999-06-14 2010-02-02 Henry Ford Health System Nitric oxide donors for inducing neurogenesis
JP3983951B2 (ja) * 1999-10-20 2007-09-26 株式会社 伊藤園 滋養強壮剤及び滋養強壮飲食物
WO2001074352A1 (fr) * 2000-04-05 2001-10-11 Taiyo Kagaku Co., Ltd. Compositions somniferes
JP3730522B2 (ja) * 2000-07-21 2006-01-05 太陽化学株式会社 喫煙欲求抑制組成物
JP5122709B2 (ja) * 2001-06-11 2013-01-16 太陽化学株式会社 精神集中向上用組成物
CN100341499C (zh) 2001-04-24 2007-10-10 太阳化学株式会社 精神集中提高用组合物
JP4955861B2 (ja) * 2001-04-24 2012-06-20 太陽化学株式会社 精神集中向上用組成物
JP3907964B2 (ja) * 2001-04-25 2007-04-18 株式会社 伊藤園 精神疲労軽減組成物、集中力維持増強組成物及び精神的活力維持増強組成物
JP4812968B2 (ja) * 2001-06-06 2011-11-09 太陽化学株式会社 注意欠陥多動性障害改善用組成物
JP5300167B2 (ja) * 2001-08-24 2013-09-25 太陽化学株式会社 気分障害治療用組成物
JP3583410B2 (ja) * 2001-11-29 2004-11-04 明治乳業株式会社 可食飲食物の抽出および/または搾汁方法
US7514107B2 (en) * 2002-03-21 2009-04-07 Mars, Incorporated Treatment of diseases involving defective gap junctional communication
US20030203072A1 (en) * 2002-04-26 2003-10-30 Team Nrg, Inc. Rehydration beverage
US7585523B2 (en) * 2002-08-27 2009-09-08 Targeted Medical Pharma Composition and method to augment and sustain neurotransmitter production
US6951658B1 (en) * 2003-07-08 2005-10-04 Pearson Research & Development Limited Emu-based compositions for mental well-being and method of use
US20050090512A1 (en) * 2003-10-28 2005-04-28 Kurt-Reiner Geiss Method of treating extreme physical or mental stress using L-theanine to obtain accelerated regeneration
US7232585B2 (en) * 2004-06-24 2007-06-19 Xel Herbaceuticals, Inc. Green tea formulations and methods of preparation
GB0418917D0 (en) * 2004-08-25 2004-09-29 Unilever Plc Process for making tea
US7666452B2 (en) * 2006-01-25 2010-02-23 Ito En, Ltd. Beverage comprising cathechins and caffeine
GB0419691D0 (en) * 2004-09-04 2004-10-06 Unilever Plc Process for making tea
JPWO2006033300A1 (ja) * 2004-09-22 2008-05-15 太陽化学株式会社 密封容器入り飲料
GB0421832D0 (en) * 2004-10-01 2004-11-03 Unilever Plc Process for making tea extracts
GB0421830D0 (en) * 2004-10-01 2004-11-03 Unilever Plc Process for making tea extracts
JP2006265177A (ja) * 2005-03-24 2006-10-05 Taiyo Kagaku Co Ltd チック障害改善用組成物
RU2428887C2 (ru) * 2005-07-22 2011-09-20 Унилевер Н.В. Предшественник напитка и способ его получения
US20070172510A1 (en) * 2006-01-23 2007-07-26 Melton Marc R Energy drink
WO2007098931A1 (en) * 2006-03-03 2007-09-07 Unilever Plc Process for preparing a tea product
KR20090010172A (ko) * 2006-03-23 2009-01-29 허발사이언스 싱가포르 피티이 리미티드 녹차 종을 포함하는 추출물 및 방법
US20080044539A1 (en) * 2006-05-03 2008-02-21 Daniel Perlman Astringency-compensated polyphenolic antioxidant-containing comestible composition
EP1891862B1 (en) * 2006-07-24 2012-04-18 Unilever PLC Beverage precursor
US8465782B2 (en) * 2006-09-21 2013-06-18 Immune Guard, LLC Methods and materials for reducing risk of cold and/or flu
JP4903875B2 (ja) * 2006-10-06 2012-03-28 ユニリーバー・ナームローゼ・ベンノートシヤープ 茶葉製品およびその製造方法

Also Published As

Publication number Publication date
AU2005313636A1 (en) 2006-06-15
RU2009145221A (ru) 2011-06-20
AR051704A1 (es) 2007-01-31
EP2108270B1 (en) 2011-03-09
PT1819241E (pt) 2014-07-25
JP2006158398A (ja) 2006-06-22
SA05260394B1 (ar) 2009-03-11
ES2359042T3 (es) 2011-05-17
US20060159829A1 (en) 2006-07-20
WO2006061097A1 (en) 2006-06-15
PL2108270T3 (pl) 2011-08-31
PT2108270E (pt) 2011-04-18
AU2005313636B2 (en) 2009-10-01
PL1819241T3 (pl) 2014-07-31
RU2007125709A (ru) 2009-01-20
PL2108270T5 (pl) 2016-09-30
EP1819241A1 (en) 2007-08-22
CN101076259A (zh) 2007-11-21
DE602005026878D1 (de) 2011-04-21
MY144727A (en) 2011-10-31
EP2108270B2 (en) 2015-11-04
JP4499652B2 (ja) 2010-07-07
JP2010063471A (ja) 2010-03-25
EP1819241B1 (en) 2014-04-30
MX2007006633A (es) 2007-06-19
RU2392836C2 (ru) 2010-06-27
RU2494654C2 (ru) 2013-10-10
CA2589696A1 (en) 2006-06-15
CN101076259B (zh) 2011-09-14
ZA200704521B (en) 2008-08-27
EP2108270A1 (en) 2009-10-14
ATE500753T1 (de) 2011-03-15

Similar Documents

Publication Publication Date Title
BRPI0517122A (pt) composição, seu uso e método para a melhora da concentração do foco mental e/ou da disposição
BRPI0609711B8 (pt) uso de uma solução aquosa com potencial redutivo oxidativo (orp)
BRPI0513085A (pt) 8-pirrolidinoxantinas bicìclicas substituìdas, e uso das mesmas como inibidoras de dipeptidil peptidase
ECSP10010310A (es) Nuevos compuestos y composiciones y métodos de uso
ECSP067043A (es) Derivados de pirrolotriazina útiles para tratar trastornos hiper-proliferativos y enfermedades asociadas con angiogénesis
BRPI0514091A (pt) 8-aminoalquiltioxantinas substituìdas, e seu uso como inibidores de dipepetidil peptidase iv
EA200702358A1 (ru) Комбинация ингибитора pde4 и производного тетрагидробиоптерина
ATE483520T1 (de) Verwendung von stevensit zur mykotoxinadsorption
MX2009002496A (es) Combinaciones que contienen un derivado de 4-acilaminopiridina.
CL2007002684A1 (es) Combinacion que comprende un antipsicotico y (2s)-(4e)-n-metil-5-[3-(5-isopropoxipiridin)il]-4-penten-2-amina; composicion farmaceutica que la comprende; kit farmaceutico; y uso para tratar perjuicio cognitivo y/o trastorno psicoticos.
BRPI0700738A (pt) artigo absorvente passìvel de disposição em pregas
BRPI0815672B8 (pt) guia de broca tendo um batente limitador e conjunto
CO5660275A2 (es) Composicion que comprende un inhibidor de pde4 y un inhibidor de pde5
BRPI0507645A (pt) anticorpo, método de detectar um distúrbio ósseo metabólico, kit para detectar um distúrbio ósseo metabólico, composição farmacêutica para o tratamento de um distúrbio ósseo metabólico, e, método de triar uma substáncia efetiva para tratar e/ou prevenir um distúrbio ósseo metabólico
BRPI0607043A2 (pt) lacosamida para terapia de adição
BRPI0416566A (pt) tratamento de fenilcetonúrias com bh4
CR10172A (es) Uso de derivados de sulfamida heterociclica benzo-fusionada para el tratamiento de abuso y adicción de sustancias
CO5150236A1 (es) Metodo para tratar asma inducida por el ejercicio inducida por el ejercicio
ECSP045490A (es) Uso de pulullan como un carbohidrato de digestion lenta
SV2003000887A (es) Compuestos de ppar ref.pc11022aado/bb
DE60228722D1 (de) Zusammensetzung und ihre verwendungszwecke zur bekämpfung von kater
GT200600106A (es) Agentes endoparasiticidas
TW200728295A (en) Benzochromene derivatives
BRPI0512392A (pt) composições contendo aequorina e uso da aequorina
BR0013625A (pt) Composição para uso no tratamento de carcinoma hepatocelular

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AO NAO RECOLHIMENTO DA 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2210 DE 14/05/2013.

B15K Others concerning applications: alteration of classification

Ipc: A23F 3/30 (2006.01), A23F 3/14 (2006.01), A23F 3/1